Adverse events involving intravenous patient-controlled analgesia

American Journal of Health-System Pharmacy

Volumn 64, Issue 14, 2007, Pages 1492-1499

  Hankin, Cheryl S ^a   Schein, Jeff ^b   Clark, John A ^c   Panchal, Sunil ^d  

^a BioMedEcon LLC   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

^c UNITED BIOSOURCE CORPORATION   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Devices; Drugs, adverse reactions; Errors, medication; Food and Drug Administration (U.S.); Opiates; Patient controlled analgesia; Reports

Indexed keywords

CITALOPRAM; FENTANYL; HYDROMORPHONE; KETOROLAC; MORPHINE; NALOXONE; OPIATE; OPIATE ANTAGONIST; PETHIDINE;

ARTICLE; BLURRED VISION; COMA; DEATH; DEVICE; DIZZINESS; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; INCIDENCE; INFUSION PUMP; INTRAVENOUS ANESTHESIA; MEDICAL DOCUMENTATION; MEDICATION ERROR; OUTCOME ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY ARREST; SAFETY; SEDATION; SEIZURE; SIDE EFFECT; UNCONSCIOUSNESS;

EID: 34447556985     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060220     Document Type: Article

References (56)

1. Cohen MR, Kilo CM. High-alert medications: safeguarding against errors. In: Cohen MR, ed. Medication errors. Washington, DC: American Pharmaceutical Association; 1999.
2. Baranowski L. Presidential address: take ownership. J Intraven Nurs. 1995; 18:162-4.
3. Flynn F, Mohr L, Lawlor-Klean P. Right programming of pumps to prevent errors in the infusion process. Jt Comm J Qual Saf. 2003; 29:37-40,1.
4. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995; 274:29-34.
5. Walder B, Schafer M, Henzi I et al. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiol Scand. 2001; 45:795-804.
6. Miaskowski C. Patient-controlled modalities for acute postoperative pain management. J Perianesth Nurs. 2005; 20:255-67.
7. Williams C. Patient-controlled analgesia: a review of the literature. J Clin Nurs. 1996; 5:139-47.
8. Ashburn MA, Love G, Pace NL. Respiratory-related critical events with intravenous patient-controlled analgesia. Clin J Pain. 1994; 10:52-6.
9. Brown SL, Bogner MS, Parmentier CM et al. Human error and patient-controlled analgesia pumps. J Intraven Nurs. 1997; 20:311-6.
10. Eade DM. Patient-controlled analgesia-eliminating errors. Nurs Manage. 1997; 28:38-40.
11. Finger MJ, McLeod DG. Postoperative myocardial infarction after radical cystoprostatectomy masked by patient-controlled analgesia. Urology. 1995; 45:155-7.
12. Grover ER, Heath ML. Patient-controlled analgesia. A serious incident. Anaesthesia. 1992; 47:402-4.
13. Notcutt WG, Knowles P, Kaldas R. Overdose of opioid from patient-controlled analgesia pumps. Br J Anaesth. 1992; 69:95-7.
14. Owen H, Mather LE, Rowley K. The development and clinical use of patient-controlled analgesia. Anaesth Intensive Care. 1988; 16:437-47.
15. White PF. Use of patient-controlled analgesia for management of acute pain. JAMA. 1988; 259:243-7.
16. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003; 290:1868-74.
17. Musshoff F, Padosch SA, Madea B. Death during patient-controlled analgesia: piritramide overdose and tissue distribution of the drug. Forensic Sci Int. 2005; 154:247-51.
18. Vicente KJ, Kada-Bekhaled K, Hillel G et al. Programming errors contribute to death from patient-controlled analgesia: case report and estimate of probability. Can J Anaesth. 2003; 50:328-32.
19. Stevens DS, Cohen RI, Kanzaria RV et al. "Air in the syringe": patient-controlled analgesia machine tampering. Anesthesiology. 1991; 75:697-9.
20. Costigan SN. Malfunction of a disposable PCA device. Anaesthesia. 1994; 49:352.
21. Williams MA, MacKrodt K. A faulty PCA device. Anaesthesia. 2001; 56:391-2.
22. Whipple JK, Quebbeman EJ, Lewis KS et al. Identification of patient-controlled analgesia overdoses in hospitalized patients: a computerized method of monitoring adverse events. Ann Pharmacother. 1994; 28:655-8.
23. Notcutt WG, Morgan RJ. Introducing patient-controlled analgesia for postoperative pain control into a district general hospital. Anaesthesia. 1990; 45:401-6.
24. Callan CM. An analysis of complaints and complications with patient-controlled analgesia. In: Ferrante FM, Ostheimer GW, Covino BG, eds. Patient-controlled analgesia. Oxford, England: Blackwell Scientific Publications; 1990:139-50.
25. Food and Drug Administration Centers for Devices and Radiological Health. Medical device reporting for manufacturers. Department of Health and Human Services. www.fda.gov/cdrh/manual/mdrman.html (accessed 2006 Jul 19).
26. Federal Drug Administration Centers for Devices and Radiological Health. Medical device reporting (MDR) - general information. www.fda.gov/cdrh/mdr/mdr- general.html (accessed 2006 Jul 19).
27. Food and Drug Administration Centers for Devices and Radiological Health. Medical device reporting for user facilities. Department of Health and Human Services. www.fda.gov/cdrh/mdr/ (accessed 2006 Jul 19).
28. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004; 140:795-801.
29. Samore MH, Evans RS, Lassen A et al. Surveillance of medical device-related hazards and adverse events in hospitalized patients. JAMA. 2004; 291:325-34.
30. Leavitt SB. Using patient-controlled analgesia (PCA) for acute pain management: an online continuing education course for nursing and pharmacy professionals. Baxter Healthcare Corporation. Online Home Study; 2004. www.baxter.com/services/training_and_education/index.html (accessed 2007 May 9).
31. Leape LL. Error in medicine. JAMA. 1994; 272:1851-7.
32. Kohn L, Corrigan J, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.
33. Brennan TA, Leape LL, Laird NM et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991; 324:370-6.
34. Kalish RL, Daley J, Duncan CC et al. Costs of potential complications of care for major surgery patients. Am J Med Qual. 1995; 10:48-54.
35. Thomas EJ, Studdert DM, Newhouse JP et al. Costs of medical injuries in Utah and Colorado. Inquiry. 1999; 36:255-64.
36. Johnson WG, Brennan TA, Newhouse JP. The economic consequences of medical injuries. Implications for a no-fault insurance plan. JAMA. 1992; 267:2487-92.
37. Lin L, Vicente KJ, Doyle DJ. Patient safety, potential adverse drug events, and medical device design: a human factors engineering approach. J Biomed Inform. 2001; 34:274-84.
38. Husch M, Sullivan C, Rooney D et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005; 14:80-6.
39. Hatcher I, Sullivan M, Hutchinson J et al. An intravenous medication safety system: preventing high-risk medication errors at the point of care. J Nurs Adm. 2004; 34:437-9.
40. Karpa DK. Radiologists take issue with new USP report on drug errors. www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=308968 (accessed 2006 Jul 19).
41. USP Center for the Advancement of Patient Safety. Patient-controlled analgesia pumps. Sep 2004, No. 81. www.usp.org/patientSafety/newsletters/ qualityReview/qr812004-09-01.html (accessed 2006 Jul 19).
42. Hicks RW, Becker SC. An overview of intravenous-related medication administration errors as reported to MEDMARX, a national medication error-reporting program. J Infus Nurs. 2006; 29:20-7.
43. Cooper JB, Newbower RS, Long CD et al. Preventable anesthesia mishaps: a study of human factors. Anesthesiology. 1978; 49:399-406.
44. Wilson RM, Harrison BT, Gibberd RW et al. An analysis of the causes of adverse events from the Quality in Australian Health Care Study. Med J Aust. 1999; 170:411-5.
45. Bates DW, O'Neil AC, Petersen LA et al. Evaluation of screening criteria for adverse events in medical patients. Med Care. 1995; 33:452-62.
46. Stanhope N, Crowley-Murphy M, Vincent C et al. An evaluation of adverse incident reporting. J Eval Clin Pract. 1999; 5:5-12.
47. O'Neil AC, Petersen LA, Cook EF et al. Physician reporting compared with medical-record review to identify adverse medical events. Ann Intern Med. 1993; 119:370-6.
48. Expert Group on Learning About Adverse Events in the NHS. An organisation with a memory. London, England: Stationery Office; 2000.
49. Cullen DJ, Bates DW, Small SD et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995; 21:541-8.
50. Jha AK, Kuperman GJ, Teich JM et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998; 5:305-14.
51. Classen DC, Pestotnik SL, Evans RS et al. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991; 266:2847-51.
52. Gardner S, Flack M. Designing a medical device surveillance network: FDA report to Congress; 1999.
53. Milch CE, Salem DN, Pauker SG et al. Voluntary electronic reporting of medical errors and adverse events. An analysis of 92,547 reports from 26 acute care hospitals. J Gen Intern Med. 2006; 21:165-70.
54. Lawton R, Parker D. Barriers to incident reporting in a healthcare system. Qual Saf Health Care. 2002; 11:15-8.
55. Taylor JA, Brownstein D, Christakis DA et al. Use of incident reports by physicians and nurses to document medical errors in pediatric patients. Pediatrics. 2004; 114:729-35.
56. Greenfield LJ. Medical device adverse event reports and the Food and Drug Administration. J Vasc Surg. 2004; 40:395-6.